Molecular Partners AG

MOLN · SWISS

$3.67+$0.0608 (+1.68%)TodayMarket closed · Oct 23, 4:00 PM ET

Prev close $3.61

About MOLN

Molecular Partners AG engages in the provision of development of protein therapies for treatment of serious diseases like cancer and sight-threatening disorders. The firm has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.

Employees: 134
Headquarters: Schlieren, Zuerich
Listed: Oct 22, 2014
Sector: Health Care
Industry: Biotechnology
Website: molecularpartners.com

Leadership

Molecular Partners AG executives
Name	Title	Since	Age
William Burns	—	—	78
Patrick Amstutz	—	2006	49
Alexander Zuercher	—	—	49
Renate Gloggner	—	—	54
Michael Stumpp	—	—	52
Martin Steegmaier	—	—	—
Philippe Legenne	—	—	59
Agnete Fredriksen	—	—	47
Dominik Hoechli	—	—	57
Steven Holtzman	—	—	71
Sandip Kapadia	—	—	55
Vito Palombella	—	—	62
Michael Vasconcelles	—	—	61
Seth Lewis	—	2024	—

Similar companies

Companies in the same industry as Molecular Partners AG

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.